BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) was the target of unusually large options trading on Monday. Stock investors acquired 2,478 call options on the stock. This is an increase of approximately 59% compared to the average volume of 1,554 call options. Analyst Ratings Changes Separately, Needham & Company LLC reiterated a “buy” rating […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight analysts that are currently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the […]
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up to $5 69 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year […]
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) was upgraded by equities research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, FlyOnTheWall reports. Other research analysts have also issued research reports about the company. StockNews.com lowered BioCryst Pharmaceuticals from a […]